Attached files

file filename
EX-99.1 - PRESS RELEASE- LAUNCH OF THE NORDLYS SYSTEM AND ASSOCIATED 2017 REVENUE EXPECTAT - STRATA Skin Sciences, Inc.ex_99-1.htm


 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

_____________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): April 26, 2017


STRATA SKIN SCIENCES, INC.
(Exact Name of Registrant Specified in Charter)
 

 
 
Delaware
000-51481
13-3986004
(State or Other
(Commission File
(I.R.S. Employer
Jurisdiction of
Number)
Identification No.)
Incorporation)
 
 


 
100 Lakeside Drive, Suite 100, Horsham, Pennsylvania
       19044
 
 
(Address of Principal Executive Offices)
(Zip Code)
 

Registrant's telephone number, including area code:   215-619-3200

N/A
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))    

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
- 1 -


 
Item 8.01 Other Events.
On April 27, 2017 STRATA Skin Sciences, Inc. (the "Company") announced the introduction of the Nordlys device at the American Society for Lasers in Medicine and Surgery meeting in San Diego, CA and the Company's forecasted revenue and EBITDA contributions for 2017 sales of Nordlys systems.

In connection with this event, the Company issued a press release, a copy of which is attached as Exhibit 99.1 and is incorporated herein by reference.
 

Item 9.01           Financial Statements and Exhibits

Exhibit No.        Exhibit Description
99.1                    Press Release dated April 27, 2017


- 2 -



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
STRATA SKIN SCIENCES, INC.
 
By:
/s/ Christina Allgeier                    
 
 
Christina Allgeier     
 
 
Chief Financial Officer
 

Date:  April 27, 2017




- 3 -




Exhibit Index


Exhibit No.          Exhibit Description
99.1          Press Release dated April 27, 2017
 


- 4 -